Juniorprofessur für chronisch entzündliche Darmerkrankungen

Reallocation / Closing: 31/12/2016
Address:
Ulmenweg 18
91054 Erlangen


Publications

Go to first page Go to previous page 1 of 3 Go to next page Go to last page

Klenske, E., Atreya, R., Zundler, S., Fischer, S.M., Neurath, M., & Rath, T. (2019). CONFOCAL LASER ENDOMICROSCOPY CAN PREDICT MAJOR CLINICAL EVENTS WITH VERY HIGH SENSITIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES. In GASTROINTESTINAL ENDOSCOPY (pp. AB68-AB68). San Diego, CA, US: NEW YORK: MOSBY-ELSEVIER.
Klenske, E., Bojarski, C., Waldner, M., Rath, T., Neurath, M., & Atreya, R. (2019). Targeting mucosal healing in Crohn’s disease: what the clinician needs to know. Therapeutic Advances in Gastroenterology, 12. https://dx.doi.org/10.1177/1756284819856865
Scarozza, P., Schmitt, H., Monteleone, G., Neurath, M., & Atreya, R. (2019). Oligonucleotides-A Novel Promising Therapeutic Option for IBD. Frontiers in Pharmacology, 10. https://dx.doi.org/10.3389/fphar.2019.00314
Ruder, B., Atreya, R., & Becker, C. (2019). Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases. International Journal of Molecular Sciences, 20(8). https://dx.doi.org/10.3390/ijms20081887
Vitali, F., Naegel, A., Atreya, R., Zopf, S., Neufert, C., Siebler, J.,... Rath, T. (2019). Comparison of Hemospray (R) and Endoclot (TM) for the treatment of gastrointestinal bleeding. World Journal of Gastroenterology, 25(13), 1592-1602. https://dx.doi.org/10.3748/wjg.v25.i13.1592
Atreya, R., Schmitt, H., Fischer, S.M., Neurath, M., Rekalde, X., Nagore, D., & Ametzazurra, A. (2019). Point of Care detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the biosimilar SB2: performance comparison with ELISA. In JOURNAL OF CROHNS & COLITIS (pp. S391-S391). OXFORD: OXFORD UNIV PRESS.
Zundler, S., Becker, E., Spocinska, M., Slawik, M., Parga-Vidal, L., Stark, R.,... Neurath, M. (2019). Hobit- and Blimp-1-driven CD4(+) tissue-resident memory T cells control chronic intestinal inflammation. Nature Immunology, 20(3), 288-+. https://dx.doi.org/10.1038/s41590-018-0298-5
Hirschmann, S., Koehnen, J., Schuster, B., Atreya, R., Krauss, N., Mudter, J.,... Albrecht, H. (2019). Addiction in IBD patients: more than just smoke? In JOURNAL OF CROHNS & COLITIS (pp. S502-S503). OXFORD: OXFORD UNIV PRESS.
Klenske, E., Atreya, R., Hartmann, A., Fischer, S., Hirschmann, S., Zundler, S.,... Rath, T. (2019). Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histological inflammation in patients with inflammatory bowel disease. In JOURNAL OF CROHNS & COLITIS (pp. S70-S71). OXFORD: OXFORD UNIV PRESS.
Kucharzik, T., Dignass, A.U., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K.,... Siegmund, B. (2019). Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS): AWMF Registry 021/009. Zeitschrift für Gastroenterologie, 57(2), 162-241. https://dx.doi.org/10.1055/a-0824-0861
Klenske, E., Osaba, L., Nagore, D., Rath, T., Neurath, M., & Atreya, R. (2019). Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn's Disease. Journal of Crohns & Colitis, 13(2), 267-269. https://dx.doi.org/10.1093/ecco-jcc/jjy153
Lichnog, C., Klabunde, S., Becker, E., Fuh, F., Tripal, P., Atreya, R.,... Zundler, S. (2019). Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. Frontiers in Pharmacology, 10. https://dx.doi.org/10.3389/fphar.2019.00039
Vitali, F., Naegel, A., Atreya, R., Zopf, S., Neufert, C., Siebler, J.,... Rath, T. (2019). Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleeding. World Journal of Gastroenterology, 25(13), 1592-1602. https://dx.doi.org/10.3748/wjg.v25.i13.1592
Schleier, L., Wiendl, M., Heidbreder, K., Binder, M.T., Atreya, R., Rath, T.,... Zundler, S. (2019). Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing. Gut. https://dx.doi.org/10.1136/gutjnl-2018-316772
Brunner, M., Agaimy, A., Atreya, R., Grützmann, R., & Matzel, K.E. (2019). Cap polyposis in children: case report and literature review. International Journal of Colorectal Disease, 34(2), 363-368. https://dx.doi.org/10.1007/s00384-018-3192-6
Zundler, S., Dietz, L., Matzel, K.E., Geppert, C., Becker, E., Rath, T.,... Atreya, R. (2018). Successful Long-term Treatment of Diversion Colitis with Topical Coconut Oil Application. American Journal of Gastroenterology, 113(12), 1908-1910. https://dx.doi.org/10.1038/s41395-018-0394-z
Görtz, R., Klett, D., Wildner, D., Atreya, R., Neurath, M., & Strobel, D. (2018). Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study. Acta Radiologica, 59(10), 1149-1156. https://dx.doi.org/10.1177/0284185117752032
Klenske, E., Neurath, M., Atreya, R., & Rath, T. (2018). Molecular imaging in gastroenterology: A route for personalized endoscopy. Digestive and Liver Disease, 50(9), 878-885. https://dx.doi.org/10.1016/j.dld.2018.06.009
Panaccione, R., Atreya, R., Ferrante, M., Dubinsky, M.C., Sands, B.E., Abreu, M.T.,... Pangan, A.L. (2018). Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn's disease: Data from the CELEST study. (pp. S412-S413).
Binder, M.-T., Becker, E., Wiendl, M., Schleier, L., Fuchs, F., Leppkes, M.,... Zundler, S. (2018). Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s. Inflammatory Bowel Diseases, 24(6), 1237-1250. https://dx.doi.org/10.1093/ibd/izy077

Last updated on 2019-24-04 at 18:16